Mutations truncating the EP300 acetylase in human cancersSimon A. Gayther, Carlos Caldas, Sarah J. Batley et al.|Nature Genetics|2000Cited by 593
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian CancerTimothy R. Rebbeck, Saundra S. Buys, Nandita Mitra et al.|JAMA|2015Cited by 507
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J. Ramus, Simon A. Gayther, Honglin Song et al.|JNCI Journal of the National Cancer Institute|2015Cited by 441
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association ConsortiumCatherine M. Olsen, Aleksandra Gentry‐Maharaj, Harvey A. Risch et al.|Endocrine Related Cancer|2013Cited by 230
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>Xin Yang, Mark E. Robson, Honglin Song et al.|JNCI Journal of the National Cancer Institute|2020Cited by 163